Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 213 entries
Sorted by: Best Match Show Resources per page
Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients.

Journal of clinical gastroenterology

Hayashi T, Miwa H.
PMID: 33337642
J Clin Gastroenterol. 2022 Jan 01;56(1):e64-e70. doi: 10.1097/MCG.0000000000001473.

GOALS: This survey aims to determine relevant patient characteristics, treatment satisfaction, and bothersome symptoms in Japanese patients with chronic constipation (CC) treated at medical institutions.BACKGROUND: Epidemiological surveys of Japanese patients with CC are limited.STUDY: This internet survey, conducted in...

Cite
Hayashi T, Miwa H. Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients. J Clin Gastroenterol. 2022;56(1):e64-e70doi: 10.1097/MCG.0000000000001473.
Hayashi, T., & Miwa, H. (2022). Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients. Journal of clinical gastroenterology, 56(1), e64-e70. https://doi.org/10.1097/MCG.0000000000001473
Hayashi, Toshihiro, and Miwa, Hiroto. "Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients." Journal of clinical gastroenterology vol. 56,1 (2022): e64-e70. doi: https://doi.org/10.1097/MCG.0000000000001473
Hayashi T, Miwa H. Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients. J Clin Gastroenterol. 2022 Jan 01;56(1):e64-e70. doi: 10.1097/MCG.0000000000001473. PMID: 33337642; PMCID: PMC8647691.
Copy Download .nbib Format: NLM
Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis.

Journal of clinical gastroenterology

Wong RJ, Hubbard A, Bagley L, Shiau R, Chitnis AS.
PMID: 34009841
J Clin Gastroenterol. 2021 Apr 09; doi: 10.1097/MCG.0000000000001533. Epub 2021 Apr 09.

BACKGROUND: While patients with hepatitis B virus (HBV) infection and tuberculosis (TB) have similar risk factors, little is known regarding the prevalence of HBV and TB coinfection. We aim to evaluate the prevalence of HBV among patients with TB...

Cite
Wong RJ, Hubbard A, Bagley L, et al. Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001533.
Wong, R. J., Hubbard, A., Bagley, L., Shiau, R., & Chitnis, A. S. (2021). Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001533
Wong, Robert J, et al. "Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001533
Wong RJ, Hubbard A, Bagley L, Shiau R, Chitnis AS. Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis. J Clin Gastroenterol. 2021 Apr 09; doi: 10.1097/MCG.0000000000001533. Epub 2021 Apr 09. PMID: 34009841.
Copy Download .nbib Format: NLM
Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis.

Journal of clinical gastroenterology

Rubin JB, Lai JC, Shui AM, Hohmann SF, Auerbach A.
PMID: 34653064
J Clin Gastroenterol. 2021 Oct 14; doi: 10.1097/MCG.0000000000001624. Epub 2021 Oct 14.

GOALS/BACKGROUND: Pain is common among cirrhosis patients, particularly those hospitalized with acute illness. Managing pain in this population is challenging due to concern for adverse events and lack of guidelines for analgesic use. We sought to characterize analgesic use...

Cite
Rubin JB, Lai JC, Shui AM, et al. Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001624.
Rubin, J. B., Lai, J. C., Shui, A. M., Hohmann, S. F., & Auerbach, A. (2021). Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001624
Rubin, Jessica B, et al. "Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001624
Rubin JB, Lai JC, Shui AM, Hohmann SF, Auerbach A. Cirrhosis Inpatients Receive More Opioids and Fewer Nonopioid Analgesics Than Patients Without Cirrhosis. J Clin Gastroenterol. 2021 Oct 14; doi: 10.1097/MCG.0000000000001624. Epub 2021 Oct 14. PMID: 34653064.
Copy Download .nbib Format: NLM
Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors.

Journal of clinical gastroenterology

Nikaido M, Miyamoto S, Utsumi T, Shimizu T, Nakanishi Y, Kumagai K, Teramura M, Setoyama T, Seno H.
PMID: 34107516
J Clin Gastroenterol. 2021 Jun 09; doi: 10.1097/MCG.0000000000001577. Epub 2021 Jun 09.

GOAL: This study investigated whether gastric hyperplastic polyps (GHPs) shrink after discontinuation of proton pump inhibitor (PPI) alone.BACKGROUND: Long-term use of PPIs has been reported to increase the incidence of GHPs, which sometimes bleed and cause anemia. We experienced...

Cite
Nikaido M, Miyamoto S, Utsumi T, et al. Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001577.
Nikaido, M., Miyamoto, S., Utsumi, T., Shimizu, T., Nakanishi, Y., Kumagai, K., Teramura, M., Setoyama, T., & Seno, H. (2021). Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001577
Nikaido, Mitsuhiro, et al. "Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001577
Nikaido M, Miyamoto S, Utsumi T, Shimizu T, Nakanishi Y, Kumagai K, Teramura M, Setoyama T, Seno H. Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors. J Clin Gastroenterol. 2021 Jun 09; doi: 10.1097/MCG.0000000000001577. Epub 2021 Jun 09. PMID: 34107516.
Copy Download .nbib Format: NLM
Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease.

Journal of clinical gastroenterology

Battat R, Qatomah A, Kopylov U, Wyse J, Cohen A, Afif W, Lakatos PL, Seidman E, Bitton A, Bessissow T.
PMID: 34739405
J Clin Gastroenterol. 2021 Nov 04; doi: 10.1097/MCG.0000000000001626. Epub 2021 Nov 04.

BACKGROUND: Fucosyltransferase 2 (FUT2) participates in intestinal antigen secretion and bacterial adherence. FUT2 homozygous nonsense mutations (FUT2M) and subsequent nonsecretor status is associated with Crohn's disease (CD). The common null allele is rs601338. We assessed the relationship between FUT2M...

Cite
Battat R, Qatomah A, Kopylov U, et al. Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001626.
Battat, R., Qatomah, A., Kopylov, U., Wyse, J., Cohen, A., Afif, W., Lakatos, P. L., Seidman, E., Bitton, A., & Bessissow, T. (2021). Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001626
Battat, Robert, et al. "Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001626
Battat R, Qatomah A, Kopylov U, Wyse J, Cohen A, Afif W, Lakatos PL, Seidman E, Bitton A, Bessissow T. Fucosyltransferase 2 Mutations Are Associated With a Favorable Clinical Course in Crohn's Disease. J Clin Gastroenterol. 2021 Nov 04; doi: 10.1097/MCG.0000000000001626. Epub 2021 Nov 04. PMID: 34739405.
Copy Download .nbib Format: NLM
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases.

Journal of clinical gastroenterology

Visaggi P, de Bortoli N, Barberio B, Savarino V, Oleas R, Rosi EM, Marchi S, Ribolsi M, Savarino E.
PMID: 34739406
J Clin Gastroenterol. 2022 Jan 01;56(1):23-35. doi: 10.1097/MCG.0000000000001629.

Artificial intelligence (AI) has enormous potential to support clinical routine workflows and therefore is gaining increasing popularity among medical professionals. In the field of gastroenterology, investigations on AI and computer-aided diagnosis (CAD) systems have mainly focused on the lower...

Cite
Visaggi P, de Bortoli N, Barberio B, et al. Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases. J Clin Gastroenterol. 2022;56(1):23-35doi: 10.1097/MCG.0000000000001629.
Visaggi, P., de Bortoli, N., Barberio, B., Savarino, V., Oleas, R., Rosi, E. M., Marchi, S., Ribolsi, M., & Savarino, E. (2022). Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases. Journal of clinical gastroenterology, 56(1), 23-35. https://doi.org/10.1097/MCG.0000000000001629
Visaggi, Pierfrancesco, et al. "Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases." Journal of clinical gastroenterology vol. 56,1 (2022): 23-35. doi: https://doi.org/10.1097/MCG.0000000000001629
Visaggi P, de Bortoli N, Barberio B, Savarino V, Oleas R, Rosi EM, Marchi S, Ribolsi M, Savarino E. Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases. J Clin Gastroenterol. 2022 Jan 01;56(1):23-35. doi: 10.1097/MCG.0000000000001629. PMID: 34739406.
Copy Download .nbib Format: NLM
Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study.

Journal of clinical gastroenterology

Lu M, Goodwin B, Vera-Llonch M, Williams J.
PMID: 33443967
J Clin Gastroenterol. 2021 Jan 12; doi: 10.1097/MCG.0000000000001491. Epub 2021 Jan 12.

GOALS: This US-based, retrospective claims study aimed to investigate disease burden and treatment patterns in patients with eosinophilic esophagitis (EoE), and to compare health care resource use (HCRU) in patients with EoE and matched controls without EoE.MATERIALS AND METHODS:...

Cite
Lu M, Goodwin B, Vera-Llonch M, et al. Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001491.
Lu, M., Goodwin, B., Vera-Llonch, M., & Williams, J. (2021). Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001491
Lu, Mei, et al. "Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001491
Lu M, Goodwin B, Vera-Llonch M, Williams J. Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study. J Clin Gastroenterol. 2021 Jan 12; doi: 10.1097/MCG.0000000000001491. Epub 2021 Jan 12. PMID: 33443967.
Copy Download .nbib Format: NLM
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.

Journal of clinical gastroenterology

Barnes EL, Hanson JS, Regueiro MD, Saha S, Sands BE, Rubin DT, Dubinsky MC, Siegel CA, Gazis DR, Crawford JM, Long MD.
PMID: 34115661
J Clin Gastroenterol. 2021 Jun 11; doi: 10.1097/MCG.0000000000001557. Epub 2021 Jun 11.

GOAL: The goal of this study was to describe medication utilization patterns in older inflammatory bowel disease (IBD) patients.BACKGROUND: Despite a growing population of older patients with Crohn's disease (CD) and ulcerative colitis (UC), questions remain regarding medication utilization...

Cite
Barnes EL, Hanson JS, Regueiro MD, et al. Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001557.
Barnes, E. L., Hanson, J. S., Regueiro, M. D., Saha, S., Sands, B. E., Rubin, D. T., Dubinsky, M. C., Siegel, C. A., Gazis, D. R., Crawford, J. M., & Long, M. D. (2021). Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001557
Barnes, Edward L, et al. "Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001557
Barnes EL, Hanson JS, Regueiro MD, Saha S, Sands BE, Rubin DT, Dubinsky MC, Siegel CA, Gazis DR, Crawford JM, Long MD. Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. J Clin Gastroenterol. 2021 Jun 11; doi: 10.1097/MCG.0000000000001557. Epub 2021 Jun 11. PMID: 34115661.
Copy Download .nbib Format: NLM
A Predictive Model for the Diagnostic and Therapeutic Yield of Colonoscopy Performed for Lower Gastrointestinal Bleeding.

Journal of clinical gastroenterology

Chung W, Rich H, Wands J.
PMID: 33471488
J Clin Gastroenterol. 2021 Jan 19; doi: 10.1097/MCG.0000000000001492. Epub 2021 Jan 19.

BACKGROUND: Although colonoscopy is routinely performed for the management of lower gastrointestinal bleeding (LGIB), the quality of evidence supporting its use is poor and its yield for active bleeding or malignancy is low in practice.METHODS: We conducted a retrospective...

Cite
Chung W, Rich H, Wands J. A Predictive Model for the Diagnostic and Therapeutic Yield of Colonoscopy Performed for Lower Gastrointestinal Bleeding. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001492.
Chung, W., Rich, H., & Wands, J. (2021). A Predictive Model for the Diagnostic and Therapeutic Yield of Colonoscopy Performed for Lower Gastrointestinal Bleeding. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001492
Chung, Waihong, et al. "A Predictive Model for the Diagnostic and Therapeutic Yield of Colonoscopy Performed for Lower Gastrointestinal Bleeding." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001492
Chung W, Rich H, Wands J. A Predictive Model for the Diagnostic and Therapeutic Yield of Colonoscopy Performed for Lower Gastrointestinal Bleeding. J Clin Gastroenterol. 2021 Jan 19; doi: 10.1097/MCG.0000000000001492. Epub 2021 Jan 19. PMID: 33471488.
Copy Download .nbib Format: NLM
Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12.

Journal of clinical gastroenterology

González González R, Jacob J, Miró Ò, Llorens P, Jiménez S, González Del Castillo J, Burillo-Putze G, Martín A, Martín-Sánchez FJ, Lamberechts JG, Alquézar-Arbé A, Higa-Sansone L, Gayoso Martín S, Carbajosa V, Beddar Chaib F, Salido M, Marchena González MJ, Calvo López R, González Martínez F, Pavón Monzo J, Velarde Herrera DM, Niembro Valdés AP, Quero Motto E, Ferreras Amez JM, Piñera-Salmerón P.
PMID: 33252555
J Clin Gastroenterol. 2022 Jan 01;56(1):e38-e46. doi: 10.1097/MCG.0000000000001465.

OBJECTIVE: The authors investigated the incidence, risk factors, clinical characteristics, and outcomes of upper gastrointestinal bleeding (UGB) in patients with coronavirus disease 2019 (COVID-19), who were attending the emergency department (ED), before hospitalization.METHODS: We retrospectively reviewed all COVID-19 patients...

Cite
González González R, Jacob J, Miró Ò, et al. Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12. J Clin Gastroenterol. 2022;56(1):e38-e46doi: 10.1097/MCG.0000000000001465.
González González, R., Jacob, J., Miró, �. �., Llorens, P., Jiménez, S., González Del Castillo, J., Burillo-Putze, G., Martín, A., Martín-Sánchez, F. J., Lamberechts, J. G., Alquézar-Arbé, A., Higa-Sansone, L., Gayoso Martín, S., Carbajosa, V., Beddar Chaib, F., Salido, M., Marchena González, M. J., Calvo López, R., González Martínez, F., Pavón Monzo, J., Velarde Herrera, D. M., Niembro Valdés, A. P., Quero Motto, E., Ferreras Amez, J. M., Piñera-Salmerón, P. (2022). Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12. Journal of clinical gastroenterology, 56(1), e38-e46. https://doi.org/10.1097/MCG.0000000000001465
González González, Rebeca, et al. "Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12." Journal of clinical gastroenterology vol. 56,1 (2022): e38-e46. doi: https://doi.org/10.1097/MCG.0000000000001465
González González R, Jacob J, Miró Ò, Llorens P, Jiménez S, González Del Castillo J, Burillo-Putze G, Martín A, Martín-Sánchez FJ, Lamberechts JG, Alquézar-Arbé A, Higa-Sansone L, Gayoso Martín S, Carbajosa V, Beddar Chaib F, Salido M, Marchena González MJ, Calvo López R, González Martínez F, Pavón Monzo J, Velarde Herrera DM, Niembro Valdés AP, Quero Motto E, Ferreras Amez JM, Piñera-Salmerón P. Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12. J Clin Gastroenterol. 2022 Jan 01;56(1):e38-e46. doi: 10.1097/MCG.0000000000001465. PMID: 33252555.
Copy Download .nbib Format: NLM
Needle-based Confocal Laser Endomicroscopy (nCLE) for Evaluation of Pancreatic Cystic Lesions: A Systematic Review and Meta-analysis.

Journal of clinical gastroenterology

Konjeti VR, McCarty TR, Rustagi T.
PMID: 33252557
J Clin Gastroenterol. 2022 Jan 01;56(1):72-80. doi: 10.1097/MCG.0000000000001468.

BACKGROUND AND AIMS: Given the variable diagnostic yield of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions (PCLs), novel imaging techniques including needle-based confocal laser endomicroscopy (nCLE) have been devised. The aim of this study was...

Cite
Konjeti VR, McCarty TR, Rustagi T. Needle-based Confocal Laser Endomicroscopy (nCLE) for Evaluation of Pancreatic Cystic Lesions: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2022;56(1):72-80doi: 10.1097/MCG.0000000000001468.
Konjeti, V. R., McCarty, T. R., & Rustagi, T. (2022). Needle-based Confocal Laser Endomicroscopy (nCLE) for Evaluation of Pancreatic Cystic Lesions: A Systematic Review and Meta-analysis. Journal of clinical gastroenterology, 56(1), 72-80. https://doi.org/10.1097/MCG.0000000000001468
Konjeti, Venkata R, et al. "Needle-based Confocal Laser Endomicroscopy (nCLE) for Evaluation of Pancreatic Cystic Lesions: A Systematic Review and Meta-analysis." Journal of clinical gastroenterology vol. 56,1 (2022): 72-80. doi: https://doi.org/10.1097/MCG.0000000000001468
Konjeti VR, McCarty TR, Rustagi T. Needle-based Confocal Laser Endomicroscopy (nCLE) for Evaluation of Pancreatic Cystic Lesions: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2022 Jan 01;56(1):72-80. doi: 10.1097/MCG.0000000000001468. PMID: 33252557.
Copy Download .nbib Format: NLM
The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD.

Journal of clinical gastroenterology

Varma S, Green PH, Krishnareddy S.
PMID: 33252560
J Clin Gastroenterol. 2022 Jan 01;56(1):e52-e57. doi: 10.1097/MCG.0000000000001470.

GOALS: We investigated the distribution of pathogens on stool gastrointestinal (GI) polymerase chain reaction (PCR) testing in those who subsequently developed inflammatory bowel disease (IBD).BACKGROUND: Infectious gastroenteritis has been associated with later development of IBD.STUDY: This retrospective study includes...

Cite
Varma S, Green PH, Krishnareddy S. The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD. J Clin Gastroenterol. 2022;56(1):e52-e57doi: 10.1097/MCG.0000000000001470.
Varma, S., Green, P. H., & Krishnareddy, S. (2022). The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD. Journal of clinical gastroenterology, 56(1), e52-e57. https://doi.org/10.1097/MCG.0000000000001470
Varma, Sanskriti, et al. "The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD." Journal of clinical gastroenterology vol. 56,1 (2022): e52-e57. doi: https://doi.org/10.1097/MCG.0000000000001470
Varma S, Green PH, Krishnareddy S. The Distribution of Gastrointestinal Pathogens on Stool PCR Prior to the Development of IBD. J Clin Gastroenterol. 2022 Jan 01;56(1):e52-e57. doi: 10.1097/MCG.0000000000001470. PMID: 33252560.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 213 entries